山东新华制药股份有限公司于2026年3月2日披露截至2026年2月28日的股份变动月报。公告显示，公司本月内无新增股票发行、回购或注销，整体股本结构保持不变。
公司注册资本为人民币696,683,435元。其中，H股（股票代码：00719）已发行股份数量为195,000,000股，A股（股票代码：000756）已发行股份数量为501,683,435股。本月两类股份的发行数量均未发生变动，库存股数量为零。
在激励计划方面，公司2021年A股股票期权计划当前授出的期权数量为1,155,000份；报告期内未有新股因该期权行使而发行，相关库存股份亦无变化。截至本月末，公司股本总数及各类股份数量均维持不变。
公司声明已遵守香港联合交易所有限公司相关上市规则及其他法律法规的要求，并确认本月所有股份事宜均已获得董事会正式授权。公告由公司秘书曹长求签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.